TUESDAY, July 16, 2019 -- Although unwelcome, insect stings pose a serious risk threat to only a small percentage of people, a medical expert says.
"While millions of people suffer insect stings, true allergic reactions occur in a mere 0.4 to 0.8% of children and up to 3% of adults," said Dr. Morissa Ladinsky. She is an associate professor of pediatrics and adolescent medicine at the University of Alabama at Birmingham.
THURSDAY, June 27, 2019 -- In what specialists say could be a turning point in care, the U.S. Food and Drug Administration on Wednesday approved the first drug to treat chronic sinusitis that involves the growth of polyps within the sinuses.
Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.